27,952 Shares in Danaher Corporation $DHR Bought by Northwestern Mutual Wealth Management Co.

Key Points

• Northwestern Mutual Wealth Management acquired 27,952 Danaher shares in the second quarter, valued at approximately $20.1 million. Institutional investors and hedge funds collectively own 79.05% of Danaher’s stock.
• Danaher exceeded quarterly expectations, reporting $1.94 in EPS versus the $1.85 consensus and $6.26 billion in revenue versus $6.12 billion expected. Revenue increased 5.5% year over year.
• Analysts maintain a generally positive outlook, with Danaher holding a “Moderate Buy” consensus rating and an average price target of $228.91, despite some recent rating and target-price reductions.

Northwestern Mutual Wealth Management Co. bought a new stake in shares of Danaher Corporation (NYSE:DHR - Free Report) in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 27,952 shares of the conglomerate's stock, valued at approximately $20,127,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Main Street Group LTD bought a new position in shares of Danaher during the 1st quarter worth about $25,000. N.E.W. Advisory Services LLC bought a new stake in shares of Danaher in the second quarter valued at about $25,000. JPL Wealth Management LLC acquired a new stake in Danaher during the third quarter worth about $25,000. WFA of San Diego LLC acquired a new stake in Danaher during the second quarter worth about $26,000. Finally, Hilton Head Capital Partners LLC bought a new position in Danaher during the fourth quarter valued at about $27,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

DHR stock opened at $219.42 on Friday. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The firm has a market cap of $154.25 billion, a PE ratio of 38.97, a P/E/G ratio of 2.72 and a beta of 0.78. The business's 50-day moving average price is $195.80 and its two-hundred day moving average price is $192.61.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company's revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.77 earnings per share. As a group, research analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages recently commented on DHR. Wall Street Zen lowered Danaher from a "buy" rating to a "hold" rating in a research note on Saturday, April 25th. DZ Bank began coverage on Danaher in a research report on Wednesday, June 3rd. They issued a "buy" rating and a $210.00 price objective for the company. Evercore reiterated an "outperform" rating and set a $230.00 target price on shares of Danaher in a research report on Monday, July 6th. Wells Fargo & Company cut their price target on Danaher from $212.00 to $195.00 and set an "equal weight" rating on the stock in a research note on Wednesday, July 22nd. Finally, Weiss Ratings raised shares of Danaher from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Wednesday, July 15th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, Danaher presently has an average rating of "Moderate Buy" and a consensus price target of $228.91.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source